Having graduated in both Law and Science Economics, he nowadays combines executive functions (as CEO of KitoZyme) with non-executive board memberships, either as Chairman of the Board or as an independent Board member. The companies in which he is - or has been - active range from SME’s, spin-offs and Research centers, such as OncoDNA, NANOCYL (a world leader in production of carbon nanotubes), Delphi Genetics, KiOmed Pharma, etc. which are active in the technology, medical or healthcare sectors to major listed companies, such as RECTICEL (industrial multinational group - Euronext) or Compagnie du BOIS SAUVAGE (diversified holding – Euronext) and public authorities, such as AWEX (export agency for the Walloon Region), AMONIS (largest pension fund for MD's in Belgium) and BioWIN. As an entrepreneur, he has (co)founded several start-ups and gained broad experience in the management of innovation driven companies. He started his career in the chemical sector and undertook assignments both in the United States and in Europe. In 1999, he joined International Brachytherapy (IBt), a medical device startup that focused on cancer treatment. He served as CEO, leading IBt, a Euronext stock listed company, from its R&D stage to a successful and well-diversified international group that became a European leader in its market segment.